FDA Approves Prostate Cancer Drug Zytiga

The FDA has approved the Johnson & Johnson pill Zytiga for use in combination with the steroid prednisone to treat a certain type of late-stage prostate cancer in men who have already been treated with chemotherapy.

Click here to read the full story.

Post a Comment
 

Enter the words shown above Enter the numbers you hear
Refresh Image Audio Help
 
Comments
No comments yet!

The Health News section does not provide medical advice, diagnosis or treatment. See additional information.

Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.